ADCTADC Therapeutics SAvs its industry peers
A metric-by-metric comparison of ADC Therapeutics SA against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADCT본 종목 | $133M#4 | — | — | 1.6x#1 | 14.9%#1 | 9.6%#6 | -149.3%#1 | — | — | — | — | — |
| AKTX | $1.62T#1 | — | 86904.8x#2 | 4392758.3x#3 | -39.5%#2 | 12.6%#5 | -4695.9%#4 | -93.0%#2 | -155.6%#1 | — | — | — |
| ALMS | $998M#3 | — | 2.2x#1 | 41.5x#2 | — | 17.3%#4 | -1886.9%#3 | -53.8%#1 | — | — | — | — |
| ANL | — | — | — | — | — | 52.5%#3 | -1058.6%#2 | — | — | — | — | — |
| APLM | $53M#5 | — | — | — | — | 68.8%#1 | — | — | — | — | — | — |
| APLMW | $24815#6 | — | — | — | — | 68.8%#1 | — | — | — | — | — | — |
| ASND | $15.3B#2 | — | — | — | — | — | — | — | — | — | 25.3%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice